INTRODUCTION
The key pathophysiological abnormalities of allergic asthma include airway hyperresponsiveness (AHR), eosinophilic inflammation, and remodeling (1) . Childhood onset disease is common, affecting about 10% of children, and is characterized by the key clinical symptom of recurrent wheeze (2) . About one-third of all children develop wheezing in the first 5 years of life, but only one-third of those will develop asthma (3) . However, the mechanisms by which allergic immune responses are initiated and the factors that mediate onset of preschool wheezing and progression to asthma are currently unidentified (4, 5) . AHR is a central feature of recurrent wheezing in children who develop asthma, and impaired lung function (6, 7) and AHR shortly after birth (8, 9) are known to be associated with asthma in adolescence and adulthood (10) .
The importance of innate immunity, specifically innate lymphoid cells (ILCs), in the inception of allergic asthma is increasingly proposed (11) . However, during pregnancy, there is a change in the uterine environment toward a T helper type 2 (T H 2) cytokine profile, and the thymic microenvironment is T H 2-skewed in the early postnatal period and undergoes age-related suppression in favor of increasing T H 1 maturation (12) . Despite this, the current dogma is that pulmonary type 2 ILCs (ILC2s), not CD4 + T cells, are the primary cellular source of type 2 cytokines [interleukin-5 (IL-5) and IL-13] in early life (13) . Although allergic asthma begins in childhood (14) , mechanistic studies of allergic airways disease had predominantly used adult experimental models (15) (16) (17) , thus disregarding the specific developmental effects of postnatal immune maturation (18) . A number of recent studies have used age-appropriate murine neonatal models and have demonstrated that, in C57BL/6 mice, perinatal type 2 immunity depends on IL-33 that is immediately up-regulated from the first day of life and drives accumulation and activation of IL-13-secreting ILC2s and pulmonary eosinophils after house dust mite (HDM) exposure (13, 19, 20) . However, the predominant clinical manifestation in infants and preschool children is recurrent wheezing with associated AHR and reduced lung function (21) , but neonatal studies to date have not investigated the mechanisms driving AHR. Age-dependent maturation of the immune system occurs after birth once the neonate encounters the antigen-rich external environment (22) . The composition of the airway bacterial profile in utero and in early life is also important because exposure to a diverse bacterial mix, such as that found on traditional cattle farms, has been shown to protect from the development of allergy and asthma (23, 24) . The capacity of the adaptive immune system to induce memory responses is limited and is thought to gradually develop after early-life environmental exposure to microbes, pollutants, and allergens (25) . A population of fetally derived CD4 + T cells with an effector memory phenotype are present in cord blood. These cells develop during fetal life but have a variety of effector inflammatory functions associated with CD4 + T helper cells at birth (26) . However, little is known about the phenotype or function of tissue-specific (pulmonary) effector T cells in early life. Studies in infants have shown that allergen-induced immune responses in whole-blood mononuclear cells can be detected at birth with IL-13 predominating after stimulation with the egg protein ovalbumin (27) . A differential developmental pattern of IL-13 versus IL-4, IL-5, and interferon- (IFN-) production was evident in infants in the first 3 months of life (28) . Although these data implicate IL-13 in the inception of early-life allergic immune responses in children, there is little direct mechanistic evidence, particularly for identification of a cellular source for IL-13 during this crucial period.
We have previously demonstrated that exposure of neonatal mice from day 3 of life to inhaled HDM promotes robust eosinophilia, T H 2 immune responses, and AHR (29) . We show here that the cellular source of type 2 mediators in neonatal mice is not restricted to ILCs but that IL-13-secreting CD4 + T cells are crucial for the development of AHR in early life. In addition, we show that IL-33, which is elevated in school-age children with severe asthma and has been linked to airway remodeling, is not a requirement for the initiation of allergic airways disease. Moreover, protection from AHR was achieved in neonatal mice using inhaled farmyard bacteria administered concomitantly with HDM, with a selective reduction in IL-13 + CD4 + T cells and IL-13, despite elevated IL-33 and IL-13 + ILCs. Our data demonstrate that the cellular source of IL-13 is essential in determining the development of early-life AHR and underpins the concept of a window of immune development in early life that has implications for the development of AHR. S1, A and B ). There are numerous published strategies to define an ILC, using combinations of extracellular markers and intracellular cytokine or transcription factor expression (31) . However, expression of cell surface markers by ILCs is variable and context-dependent (32) . Given the importance of IL-13 in driving the pathological features of early-life airways disease, we focused on cytokine-secreting cells, initially gating on pul- 
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+ T cells and IL-13 + ILCs (Fig. 1C) . Both adult and neonatal mice developed significant eosinophilia after challenge with rIL-33, and this response was greatest in adult mice (Fig. 1D) . In addition, rIL-33 increased airway resistance at both ages, concomitant with increased IL-13 levels (Fig. 1, E to H) . Levels of IL-5 were also increased in mice of both ages, although the magnitude of the response was greatest in adult mice (Fig. 1I) . Although 2 weeks of exposure to cytokine is too short to observe phenotypic changes in airway remodeling, increases in the mucin genes Muc5ac and Muc5b, the principle components of airway mucus, were observed in both neonatal and adult mice (Fig. 1, J and K) . Muc5ac has been demonstrated to be necessary for the development of AHR, is increased in asthmatic patients including children, and is regulated by levels of IL-13 (34) .
Both T cells and ILCs comprise the neonatal response to allergen
To determine the cellular source of IL-13 after exposure to an antigenically complex, clinically relevant allergen, we compared intranasal HDM exposure for 2 weeks in neonatal mice from day 3 of life to adult mice (Fig. 2) . Duration of allergen exposure was limited to 2 weeks to focus on mechanisms underlying disease inception before established adaptive allergic immunity with elevated immunoglobulin E levels. Both neonatal and adult mice developed AHR (Fig. 2, A and B) and eosinophilia ( Fig. 2C ) in response to allergen. In contrast to the immune response to rIL-33, which in adult mice skewed the IL-13-secreting cells toward an ILC2-dominated response, HDM resulted in significantly elevated numbers of IL-13 + CD4 + T cells (Fig. 2D ). In contrast, neonatal mice exposed to HDM had a mixed response with induction of both T H 2 cells and ILC2s (Fig. 2E) . However, significantly more IL-13 + CD4 + T cells were induced compared with IL-13 + ILCs (Fig. 2E) . The increase in IL-13 + cells, irrespective of their source, resulted in elevated levels of pulmonary IL-13 in adult and neonatal mice (Fig. 2F) . To extend our observations to another clinically relevant allergen, we enumerated ILCs and T cells after exposure to the fungal allergen Alternaria alternata ( fig. S2A ), which is associated with severe pediatric asthma (35) and with elevated pulmonary IL-33 (36) . In both adult and neonatal mice, inhaled A. alternata induced a strong inflammatory response with significant elevations of both IL-13 + CD4 + T cells and IL-13 + ILCs (Fig. 2 , G and H) with associated increased levels of IL-13 (Fig. 2I) . The elevated IL-13 concentration in the lung correlated with increased AHR (fig. S2 , B and C). Congruent with a type 2 inflammatory response, both adult and neonatal mice exhibited significant pulmonary eosinophilia ( fig. S2D) .
We next phenotyped the allergen-induced T cells present in neonatal lungs and compared them with adults. In the CD4 + IL-13 neg population, the proportion of cells with a memory-like phenotype (CD44 + CD62L low/neg ) was equivalent in adults and neonates (Fig. 3,  A and B) , whereas the percentage expressing CD103, an integrin associated with epithelial lymphocyte localization, and the activation markers CD69 and ICOS were greater in adults compared with 3 of 12 neonates (Fig. 3, C to F) . Examination of the CD4 + IL-13 + T cells revealed similar patterns of extracellular marker expression in cells recovered from both HDM and A. alternata-treated mice, although the proportions of cells expressing specific markers was greatest in mice administered A. alternata. In contrast to the IL-13 neg population, the proportion of IL-13 + CD4 + T cells with a memory-like phenotype was significantly higher in neonates than in adults (Fig. 3, A and B) . Likewise, more neonatal IL-13
+ T cells expressed CD103 than adults after HDM (Fig. 3, C and D) . A very high proportion of cells expressed CD69 and ICOS in adults and neonatal mice exposed to negative for the CD1d dimer expressed on natural killer (NK) T cells (Fig. 3O ).
Allergen exposure in neonatal SCID mice protects from AHR, whereas Il33 −/− mice are unaffected To determine the functional significance of the pulmonary IL-13 + CD4
+ T cells in early life, we exposed neonatal severe combined immunodeficient (SCID) mice, which lack T, B, and NK cells, to HDM for 2 weeks (fig. S3A ). While the wild-type (WT) mice showed the expected increase in AHR ( fig. S3B) , the neonatal SCID mice did not exhibit any AHR (fig. S3C) . The observed AHR in WT mice correlated with increased levels of IL-13 and IL-33, which were not apparent in SCID mice ( fig. S3, D and E) . IL-13 is known to be critical for the generation of AHR. However, the dependence of AHR on the innate cytokine IL-33 in neonates has not been investigated. Therefore, we exposed neonatal WT and Il33 −/− mice to HDM from day 3 of life. Neonatal Il33 −/− mice developed equivalent AHR and an inflammatory response of similar composition and magnitude to WT mice (Fig. 4, A to D) . IL-33 was absent in the Il33 −/− mice as expected, but the type 2 cytokines IL-5 and IL-13 were induced to similar levels in WT and knockout (KO) mice (Fig. 4 , E to G), demonstrating that, in neonatal mice, AHR is independent of IL-33 but totally reliant on IL-13. These data underscore the functional importance of perinatal IL-13
+ T cells in inducing AHR in early life and suggest that pulmonary T cells are a critical source of IL-13 in the immediate postnatal period.
Mice lacking IL-13 in CD4 + T cells do not develop AHR in response to allergen
To confirm the importance of T cell-derived IL-13 on the generation of allergen-induced AHR, we exposed either neonatal WT or (Fig. 5A ). Confirming our hypothesis, mice lacking these cells did not develop AHR after exposure to either HDM or A. alternata (Fig. 5, B and C) . We next determined the composition of the pulmonary cellular infiltrate in these mice. The number of eosinophils (Fig. 5, D and E) and IL-13 + ILCs (Fig. 5, F and G) was not significantly different between WT and Cd4-cre fl/fl mice. Likewise, T cells expressing IL-5 were not affected by the specific loss of IL-13 + CD4 + T cells (Fig. 5, H and I) . Despite the presence of increased IL-13 + ILC2 with the capacity to secrete IL-13 (Fig. 5, F and G) , there was only a minimal increase in pulmonary IL-13 levels after HDM or A. alternata exposure (Fig. 5, J and K) in the absence of IL-13
+ T cells. Expression of Muc5ac was increased in neonates exposed to both HDM and A. alternata (Fig. 5, L and M) . In mice lacking IL-13 + CD4
+ T cells, the HDM-induced increase in Muc5ac was ablated (Fig. 5L) , indicating that expression is dependent on IL-13 levels. However, in mice administered A. alternata, allergen-induced Muc5ac gene expression was maintained (Fig. 5M ). This suggests that IL-13 + ILC2s alone are not sufficient to generate levels of IL-13 necessary to drive AHR in the absence of IL-13
+ T cells in early life. Thus, mice lacking IL-13 specifically in CD4 + T cells were completely protected from developing AHR after exposure to different allergens, underscoring the importance of these cells in the inception of early-life AHR.
Therapeutic manipulation of IL-13 +
CD4
+ T cells protects neonatal mice from developing AHR Although studies using KO mice show proof of principle, to determine whether it is possible to translate these findings and therapeutically manipulate neonatal IL-13
+ T cells that drive allergen-induced changes to lung function, we investigated the mechanism of action of of two experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
an immunomodulatory agent, the lyophilized bacteria Acinetobacter lwoffii, which is associated with protection from asthma in children (17) and AHR in adult mouse models (20) . We administered A. lwoffii (a farmyard isolate with strong allergy-protective properties) intranasally concomitant with HDM to neonatal BALB/c mice from day 3 of life for 3 weeks (Fig. 6A ). Neonatal mice that received both the inhaled bacteria and HDM were completely protected from the development of AHR (Fig. 6B) . Moreover, eosinophils were significantly reduced in the mice that received A. lwoffii (Fig. 6C) . Pulmonary IL-33 levels remained elevated in all mice that received HDM and even in those that received the bacterial isolate (Fig. 6D) ; however, in keeping with the AHR results, allergen-induced IL-13 levels were almost completely abrogated in the mice that received A. lwoffii (Fig. 6E ). When we assessed the lymphoid cellular source of IL-13, numbers of IL-13 + ILCs were increased in mice that received bacteria irrespective of allergen exposure (Fig. 6F) , but IL-13 + CD4
+ T cells were significantly reduced (Fig. 6G) . Levels of allergen-induced IL-5 were unaffected by the A. lwoffii (Fig. 6H) . To further investigate how the A. lwoffii prevented the recruitment of Muc5ac gene expression in mice exposed to (L) HDM or (M) ALT. n = 6 to 8 allergen-exposed, n = 4 to 6 PBS. Data are representative of at least two experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
IL-13
+ CD4 + T cells, we enumerated pulmonary dendritic cells (DCs). In agreement with data in the literature, exposure to HDM alone resulted in a significant increase in the number of CD11b + conventional DCs (cDCs; Fig. 6I ). Plasmacytoid DC (pDC) and monocytederived DC (MoDC) numbers were also elevated. However, concomitant exposure to A. lwoffii completely blocked the expansion of CD11b 
DISCUSSION
An essential clinical feature of asthma and wheezing in childhood, including infancy and the preschool years, is the presence of AHR (37) . In addition, cohort studies have shown that the single most important factor that determines development of asthma in children is AHR in early life, which may be apparent even before the onset . n = 8 for HDM and bacteria exposed groups, n = 5 for PBS. *P < 0.05, **P < 0.01, ***P < 0.001. Data are representative of three experiments.
IL-13 + T cells
of the manifest symptom of wheezing (38) . To identify mechanisms mediating allergen-induced disease inception, and targets for intervention allowing asthma prevention, achieving a reduction in AHR is essential. However, the underlying molecular mechanisms remained unclear. AHR was the focus of this study to optimally reflect pediatric symptoms. We determined that effector IL-13 + CD4 + cells are critical for the development of AHR after exposure to either the ILC2 promoting cytokine rIL-33 or clinically relevant allergens HDM and A. alternata in the first weeks of life. IL-13 + ILCs were insufficient to compensate for an absence of IL-13 + CD4
+ T cells in early life, demonstrated by the lack of AHR in neonatal SCID mice or in mice specifically lacking IL-13 in CD4 + T cells after exposure to inhaled allergen. Mice lacking functional T and B cells or IL-13 + CD4 + T cells did not develop increased levels of IL-13 after allergen exposure from day 3 of life despite comparable numbers of IL-13 + ILCs. Moreover, administration of inhaled farm dust bacteria during exposure to HDM to neonatal mice resulted in complete protection from AHR with a significant reduction in pulmonary IL-13 + CD4 + T cells and levels of IL-13 but sustained elevation of IL-33 and IL-13 + ILCs. Collectively, these data show that, in neonatal mice, T cells are an essential early source of IL-13 to drive AHR. Our results indicate that, although ILCs have the potential to generate IL-13 when stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin in vitro, in the absence of IL-13 + CD4 + T cells in vivo, functional levels of IL-13 are not generated. Thus, despite the assumption that ILC2s initiate pulmonary allergic immune responses, this is dependent on age, and in neonatal mice, IL-13 + CD4 + T cells are critical for disease inception in early life. This has significant implications for therapies to prevent wheeze and asthma inception in childhood, because molecular targets that prevent the induction of ILC2s are unlikely to be effective in preventing early onset disease.
Key distinctions between adult and neonatal immune responses after HDM exposure were also shown in a neonatal model that used a single dose of allergen to achieve sensitization at day 3, day 14, or adult life, followed by allergen challenge a week later (13) . Similarly, previous neonatal murine studies have shown the importance of the first 2 weeks of life in causing exaggerated immune responses (39) but did not examine associated AHR or interrogate the cellular source of the mediators that potentially generate AHR. We used a model of continuous, low-dose allergen exposure rather than sensitization, followed by allergen challenge several days later, because this reflects the type of exposure that young children likely experience with perennial allergens such as HDM and A. alternata. Although ILC2s have been shown to be important in generating T H 2 immunity in experiments with papain or helminths in adult mice (40, 41) , our data indicate that, in neonatal mice, IL-13
+ T cells drive early-life allergen-induced AHR. We cannot rule out the role of T cell-derived IL-4 in neonatal allergendriven responses and, given the potential importance of IL-4, future studies are needed to clarify the relative importance of IL-4 and IL-13 production in this process. In adult mice, an elegant series of experiments using ILC-deficient mice reconstituted with naïve CD4 + T cells has also shown that activation of primed T H 2 cells is independent of ILC2s (42). However, in contrast to our findings in neonatal mice, the adult T H 2 cell activation was dependent on pulmonary IL-33. Similarly, in response to HDM or papain, adult T H 2 cells secreting IL-13 but not IL-4 have been shown to mediate TCR-independent, IL-33-dependent innate-like immune responses (43) . Thus, interactions between T H 2 cells and ILC2s are vital in developing pathophysiology but are likely to be contextual depending on environmental or temporal factors. + T cells that are present in cord blood from naïve human neonates, but are lost during aging, has also been described (44) . This distinct subpopulation of IL-4 + CD4
+ T cells was only found in neonates, but not in adults, and supports the hypothesis of an endogenously poised type 2 cytokine profile of T cells in neonates and a link between cytokine production and developmental stage (44) . Using neonatal BALB/c mice, we have shown that CD4 + T cells make a vital contribution to the pool of IL-13 in the lung that drives AHR. Caution should therefore be exercised when interpreting data from C57BL/6 mice, where allergen appears to induce ILC2s as the major source of IL-13-secreting cells in an IL-33-dependent manner (13) . An important factor that determined our use of BALB/c mice is the direct reflection of the disease phenotype of our patients with severe wheezing and asthma, incorporating a marked airway eosinophilia, AHR, and remodeling (45, 46) , in this strain and protocol of allergen exposure. Previous murine studies, also in BALB/c mice, have shown that polyclonal stimulation of lung T cells results in a bias toward IL-4 and IL-5 and increased ratio of GATA3 + T cells compared with T-bet + T cells (47) . This would appear to be an intrinsic feature of neonatal T cells because Bacille Calmette-Guérin-primed lung DCs from either neonates or adults prime adult naïve T cells toward T H 1, whereas a T H 2 cytokine response is observed from naïve neonatal T cells. Cord blood cells, which are reflective of fetal blood, showed a substantial IL-13 response to allergen stimulation in vitro, and the newborns had a T H 2 cytokine bias that was restricted to IL-13 (28) . Although these results were in peripheral blood rather than in the lung, they do indicate that early life is associated with a skewed IL-13 response. We now show that T cell-derived IL-13 is critical for the inception of allergen-induced lung function changes.
Our data highlight the critical role of T cell-derived IL-13 in the neonatal period. Neonatal mice have a population of IL-13 + CD4 + T cells that have the capacity to rapidly promote AHR when exposed to allergen. Modulating the allergen-induced increase in DCs in the lung and, consequently, in the IL-13 + CD4 + T cells, via a farm dust bacterial isolate, specifically abrogated AHR, even while IL-33 and IL-13 + ILCs were maintained. The concept of the neonatal "window of opportunity" is gathering momentum with regard to the mucosal microbiota (39), and we now know that life-long immune homeostasis and susceptibility to immune-mediated diseases (asthma, allergies, and bronchiectasis) can be shaped during the postnatal period (22, 48, 49) . The specialized neonatal adaptive immune response after birth also has a predisposition to higher expression of GATA3 + , type 2 cytokine-producing pulmonary T cells (47) as a result of both normal development and in response to environmental exposures. Here, we have shown that interventional approaches to prevent AHR and asthma in early life need to focus on reducing IL-13 + CD4
+ T cells rather than IL-13 + ILCs, highlighting the need for age-specific therapeutic approaches in infants and young children compared with adults.
MATERIALS AND METHODS
Study design
This study aimed to determine the immune mechanisms that drive the inception of AHR in neonatal mice.
Research samples
Immune cells were collected from the lung tissue of adult and neonatal mice at the times indicated depending on the experimental setup. Cord blood was collected at delivery of full-term pregnancies.
Experimental design Randomization
In all experiments, mice from the control and experimental groups came from the same cohorts, were reared under the same environmental conditions, and were age-matched. Adult female mice were randomly placed in either the control group or the experimental group. Neonatal mice were of either sex, and litters were randomly assigned to control or experimental groups.
Sample size
The number of mice analyzed for each different experimental approach is indicated on each figure. All experiments were repeated at least once with similar sample sizes and a minimum number of four mice per group. Animals and reagents WT female BALB/c and Beige SCID mice were initially obtained from Charles River (Saffron Walden, UK) and maintained by in-house breeding. Cd4-cre fl/fl mice (50) on a BALB/c background were a gift from D. Voehringer. Il33 −/− mice were a gift from MedImmune Inc. Each mother with its litter was housed separately. Mice were maintained in specific pathogen-free conditions and given food and water ad libitum. In individual experiments, all mice were matched exactly for age and background strain. All procedures were conducted in accordance with the Animals (Scientific Procedures) Act 1986. Recombinant mouse IL-33 (50 g/kg) for intranasal administration was purchased from R&D Systems (UK).
Allergen challenge
In experiments to assess the effect of allergen challenge on allergic airways disease, 3-day-old neonatal mice and adults (6 to 8 weeks) received intranasal administration of either HDM or A. alternata (Greer, Lenior, NC, USA). From birth to 2 weeks of age, mice were administered 20 g of HDM extract, 5 g of A. alternata, or 10 l of PBS, three times a week. Adult mice received 25 g of HDM or 10 g of A. alternata. All outputs were assessed at 24 hours after allergen challenge (51) . Bacteria and allergen coexposure BALB/c mice were exposed to intermittent intranasal A. lwoffii F78 [1.3 × 10 8 colony-forming units (cfu) for the first 2 weeks and then 2 × 10
8 cfu] (52) (a gift from Johann Bauer) or PBS, followed by HDM (10 g for the first 2 weeks and then 15g) or PBS for 3 weeks starting on day 3 of life for 3 weeks. All outputs were assessed 24 hours after the final challenge as described below. Measurement of AHR Airway resistance was calculated using the flexiVent small animal ventilator (SciReq) using our established protocols (29) . Mice were anesthetized with pentobarbital sodium (50 mg/kg, intraperitoneally) and ketamine (100 mg/kg, intramuscularly), tracheostomized, and connected to the flexiVent ventilator via a blunt-ended 21-gauge needle (neonate) or a 19-gauge needle (adult). The mice were ventilated with an average breathing frequency of 150 breaths/min, tidal volume of 10 ml/kg body weight, positive end-expiratory pressure of about 2 cm H 2 O. Changes in resistance to increasing concentrations of nebulized methacholine (3-100 mg/ml) were calculated from the snapshot perturbation measurements. Resultant data were fitted using multiple linear regression to the single-compartment model in the following form: pressure = resistance × flow + elastance × volume + fitting constant. Inflammation and cell recovery Bronchoalveolar lavage (BAL) was performed with PBS via a tracheal cannula. The volume of BAL fluid instilled was 3 × 200 l of aliquots for neonatal mice, 3 × 300 l of aliquots for 3-week-old mice, and 3 × 400 l of aliquots in adults (29) . After lavage, the large left lobe of the lung was mechanically chopped and incubated at 37°C for 1 hour in complete media [RPMI + 10% fetal calf serum, 2 mM l-glutamine, and penicillin/streptomycin (100 U/ml)] containing collagenase (0.15 mg/ml; Type D, Roche Diagnostics) and deoxyribonuclease (25 mg/ml; Type 1, Roche Diagnostics). Cells were recovered by filtration through a 70-m nylon sieve (Falcon, BD Biosciences, MA), washed twice, resuspended in 1-ml complete media, and counted in a hemocytometer (Immune Systems). The total cell yield was quantified by hemocytometer. All cell counts were performed blind by the same observer.
Flow cytometry
To reduce nonspecific binding, we incubated cells with rabbit serum (Sigma-Aldrich) for 15 min before staining. When staining for intracellular cytokines, single-cell suspensions were incubated at 37°C in complete RPMI for 4 hours, in the presence of PMA (20 ng/ml; SigmaAldrich), ionomycin-free acid (1.5 g/ml) from Streptomyces conglobatus (Merck), and Brefeldin A (5 g/ml; Sigma-Aldrich). Cells were subsequently washed in PBS and stained with LIVE/DEAD Fixable Blue Dead Cell Stain (Thermo Fisher Scientific/Life Technologies), as per the manufacturer's directions, before washing twice in PBS. Cell suspensions were then stained with fluorochrome-conjugated monoclonal antibodies to surface markers (see table S1) in staining buffer (PBS containing 1% bovine serum albumin and 0.01% sodium azide) for 20 min at 4°C. Cells were then washed twice in staining buffer and fixed in IC Fixation Buffer (Thermo Fisher Scientific/eBioscience) for 15 min at room temperature. Where necessary, fixed cells were permeabilized using Permeabilization Buffer (Thermo Fisher Scientific/ eBioscience) and stained with fluorochrome-conjugated antibodies to intracellular cytokines (see table S1) in Permeabilization Buffer for 20 min at 4°C. "Fluorescence minus one" controls for extracellular and intracellular antigens were used on matched tissue samples for quality control purposes and to assist with gating. Data were acquired on a BD LSR Fortessa using FACSDIVA software (both from BD Biosciences) and analyzed using FlowJo software (v10, Tree Star). For ILC identification in mouse samples, lineage exclusion gates consisting of the surface markers TCR, TCR, CD3e, CD5, CD19, CD11b, CD11c, FCR1, GR-1, F4/80, NKp46, and TER-119 were used (table S1). For ILC identification in human samples, a lineage exclusion gate consisting of CD14, CD16, CD19, CD20, CD3, and CD56 was used. Quantification of cytokines Lung tissue was homogenized at 50 mg/ml in Hanks' balanced salt solution (Gibco) containing protease inhibitor tablets (Roche Diagnostics) and centrifuged at 800g for 20 min, and the supernatant was collected. Cytokines were analyzed in lung homogenate supernatants. Paired antibodies for mouse IL-33 (R&D Systems) and IL-5 (BD Biosciences) were used in standardized sandwich enzyme-linked immunosorbent assay according to the manufacturer's protocols. IL-13 was measured using a Quantikine kit (R&D Systems) as per the manufacturer's protocol. Quantitative PCR RNA was extracted from the lung using the Qiagen RNeasy Plus Mini Kit, following the manufacturer's instructions. Reverse transcription was performed with 1 to 2 g of RNA using the High Capacity complementary DNA (cDNA) Reverse Transcription Kit (Applied Biosystems), following the manufacturer's instructions. Generated cDNA was used for quantitative real-time polymerase chain reaction (PCR) analysis using TaqMan Fast Advanced Master Mix (Applied Biosystems) and quantified on the ViiA 7 (Applied Biosystems). Relative gene expression was determined via normalization to the housekeeping gene Gapdh. All TaqMan primers were purchased from Thermo Fisher Scientific. Primers are as follows: Gapdh (Mm99999915_g1), dye: FAM-MGB; Il5 (Mm00439646_m1), dye: FAM-MGB; Il13 (Mm00434204_m1), dye: FAM-MGB; Muc5ac (Mm01276726_g1), dye: FAM-MGB; and Muc5b (Mm00466391_m1), dye: FAM-MGB.
Statistical analysis
All results were expressed as median and interquartile range, and data were analyzed using GraphPad Prism 7 software (GraphPad Software). Nonparametric tests (Mann-Whitney U) were used to detect differences between groups, and statistical significance was accepted when P < 0.05. *P <0.05, **P < 0.01, and ***P < 0.001.
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